BROOKFIELD ASSET MANAGEMENT
BAM · NYSE
About BAM
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Dec 1, 2022
- Sector
- Financials
- Industry
- Capital Markets
- Website
- bam.brookfield.com
BAM key statistics
- Market cap
- 74.06B
- Price-earnings ratio
- 0.00
- Dividend yield
- 4.08%
- Average volume
- 3.26M
- Volume
- 1.67M
- Open price
- $45.23
- High today
- $46.55
- Low today
- $45.16
- 52 Week high
- $56.42
- 52 Week low
- $42.20
BROOKFIELD ASSET MANAGEMENT (BAM) at a glance
As of Oct 20, 2026, BROOKFIELD ASSET MANAGEMENT (BAM) shares are priced at $45.93, giving the company a market cap of 74.06B, a price-to-earnings ratio of 0.00 and a dividend yield of 4.08%.
Today the stock has traded between $45.16 and $46.55. The current price is 1.7% above the day's low and 1.3% below its high.
Volume so far is 1.67M shares, below the average of 3.26M shares a day.
Over the past year BROOKFIELD ASSET MANAGEMENT has ranged from $42.20 to $56.42, and now sits 26% of the way up that range.
BROOKFIELD ASSET MANAGEMENT met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.44 per share against an estimate of $0.4463.
The average analyst price target is $58.49, 27.4% above the current price, from 10 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy40.0%
- Hold50.0%
- Sell10.0%
- Low
- $44.44
- Now
- $45.93
- High
- $73.50
BAM earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 3.5% on average.
- Q3 FY24: reported $0.38 per share against an estimate of $0.3594
- Q4 FY24: reported $0.40 per share against an estimate of $0.3942
- Q1 FY25: reported $0.40 per share against an estimate of $0.4046
- Q2 FY25: reported $0.42 per share against an estimate of $0.3935
- Q3 FY25: reported $0.41 per share against an estimate of $0.4081
- Q4 FY25: reported $0.47 per share against an estimate of $0.4436
- Q1 FY26: reported $0.43 per share against an estimate of $0.4281
- Q2 FY26: reported $0.44 per share against an estimate of $0.4463
BAM news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Brookfield Asset Management to Host Third Quarter 2026 Results Conference Call
'Brookfield to Buy ESR India Warehouse Parks in $444 Million Deal' - Bloomberg
'Blue Owl Again Caps Two BDCs After 39%, 17% Withdrawal Requests' - Bloomberg
'Carlyle Warns Private Credit’s AI Push Raises Concentration Risk' - Bloomberg
- Press releaseBusiness Wire
LXP Industrial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LXP Industrial Trust - LXP
Sky News Reported Brookfield In Advanced Talks To Buy Actimize From NICE For About $2B
- Caroline Ryan
Fortress Co-CEO Warns Private Credit On AI Deals: 'You're Not Getting Paid For That Upside'
Similar companies
Companies in the same industry as BROOKFIELD ASSET MANAGEMENT
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.